about
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug...
Read More
0.39
-0.01
(-2.50%)
15,732
XNAS Volume
XNAS 29 Aug, 2025 11:47 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Athira Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..